Vitro, S.A.B. de C.V. VITOF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.69M | 20.57M | 17.50M | 74.12M | 20.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.69M | 20.57M | 17.50M | 74.12M | 20.08M |
| Cost of Revenue | 2.23M | 3.11M | 1.21M | 56.29M | 3.27M |
| Gross Profit | 17.47M | 17.47M | 16.29M | 17.84M | 16.81M |
| SG&A Expenses | 18.40M | 19.72M | 19.04M | 49.57M | 16.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.71M | -1.61M | -3.28M | -1.44M | -1.43M |
| Total Operating Expenses | 22.33M | 21.22M | 16.97M | 104.42M | 18.22M |
| Operating Income | -2.64M | -646.00K | 524.00K | -30.30M | 1.86M |
| Income Before Tax | -14.20M | 26.99M | 10.49M | 37.04M | 34.13M |
| Income Tax Expenses | -1.03M | -17.14M | 4.36M | 6.28M | 4.97M |
| Earnings from Continuing Operations | -13.17M | 44.14M | 6.14M | 30.76M | 29.16M |
| Earnings from Discontinued Operations | 18.00K | -- | 46.66M | -- | 5.30M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.16M | 44.14M | 52.80M | 30.76M | 34.46M |
| EBIT | -2.64M | -646.00K | 524.00K | -30.30M | 1.86M |
| EBITDA | -1.06M | 1.12M | 2.03M | -20.43M | 3.82M |
| EPS Basic | -0.03 | 0.09 | 0.11 | 0.07 | 0.12 |
| Normalized Basic EPS | -0.02 | 0.03 | 0.01 | 0.02 | 0.07 |
| EPS Diluted | -0.03 | 0.09 | 0.11 | 0.07 | 0.12 |
| Normalized Diluted EPS | -0.02 | 0.03 | 0.01 | 0.02 | 0.07 |
| Average Basic Shares Outstanding | 398.93M | 490.39M | 466.63M | 439.41M | 287.15M |
| Average Diluted Shares Outstanding | 398.93M | 490.39M | 466.63M | 439.41M | 287.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |